OpenAI has acquired Orchestra Bio, a startup building AI agents to help pharmaceutical companies manage drug development, the ChatGPT maker shared exclusively with Axios. The acquisition will integrate Orchestra's team and technology into Rosalind, OpenAI's suite of AI models and tools designed for life sciences researchers.
company
Orchestra Bio
AI startup for drug development